Analysis of the potential impact of Trump's policies on growth and the stock market, including tariffs, tax cuts, and ...

David Abrams’ 13F portfolio value increased from $5.11B to $6.23B in Q3 2024, with the top three stakes comprising ~66%. The ...

Meta Platforms delivered strong Q3 results, but it's not the right time to initiate a position in the company. See why META ...

The acquisition reshapes FREYR Battery into a profitable growth company while providing immediate revenue streams. See why ...

Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Check out a few concerns with GMRE stock and why it ...

Target Resources cut its dividend in 2020 to repay debt faster, reflecting its aggressive growth strategy. See why TRGP stock ...

Insurance inflation is easing, with auto insurance seeing deflation in some areas, while home insurance remains high in ...

Invesco Water Resources is the largest of the water ETFs. Read why I'm not convinced PHO's portfolio is a particularly ...

I reiterate a 'Sell' rating on IDEXX due to weak U.S. clinical visits and demand, with a one-year price target of $400 per ...

Maxim Power's transition to a new plant and market shift increase shareholder value. Click here to read why MXG:CA stock is a ...

Corteva's Q3 results showed weak growth in Latin America, but benefits from raw material cost deflation. Read why I reiterate ...

We have had our ups and downs with Ovintiv Inc. (NYSE:OVV) (TSX:OVV:CA). We were aware of its long-term history of value ...